Literature DB >> 29367292

CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests.

Romney M Humphries1, Jane Ambler2, Stephanie L Mitchell3, Mariana Castanheira4, Tanis Dingle5,6, Janet A Hindler7, Laura Koeth8, Katherine Sei9.   

Abstract

Effective evaluations of antimicrobial susceptibility tests (ASTs) require robust study design. The Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing has recognized that many published studies reporting the performance of commercial ASTs (cASTs) suffer from major design and/or analysis flaws, rendering the results difficult or impossible to interpret. This minireview outlines the current consensus of the Methods Development and Standardization Working Group of the CLSI Subcommittee on Antimicrobial Susceptibility Testing regarding best practices for systematic evaluation of the performance of an AST, including the analysis and presentation of essential data intended for publication.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  CLSI; antimicrobial susceptibility testing; evaluations

Mesh：

Year:  2018        PMID： 29367292      PMCID： PMC5869819          DOI： 10.1128/JCM.01934-17

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

1.  Modification of the error-rate bounded classification scheme for use with two MIC break points.

Authors:  M N Brunden; G E Zurenko; B Kapik
Journal:  Diagn Microbiol Infect Dis       Date:  1992-02       Impact factor: 2.803

2.  Determination of disk diffusion susceptibility testing interpretive criteria using model-based analysis: development and implementation.

Authors:  Glen DePalma; John Turnidge; Bruce A Craig
Journal:  Diagn Microbiol Infect Dis       Date:  2016-03-02       Impact factor: 2.803

3.  Precision of vancomycin and daptomycin MICs for methicillin-resistant Staphylococcus aureus and effect of subculture and storage.

Authors:  Carmen L Charlton; Janet A Hindler; John Turnidge; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2014-08-20       Impact factor: 5.948

4.  Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae.

Authors:  Sarah M Bartsch; Susan S Huang; Kim F Wong; Rachel B Slayton; James A McKinnell; Daniel F Sahm; Krystyna Kazmierczak; Leslie E Mueller; John A Jernigan; Bruce Y Lee
Journal:  J Clin Microbiol       Date:  2016-08-31       Impact factor: 5.948

5.  Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.

Authors:  C M Metzler; R M DeHaan
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

6.  Performance of Vitek 2 for Antimicrobial Susceptibility Testing of Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia with Vitek 2 (2009 FDA) and CLSI M100S 26th Edition Breakpoints.

Authors:  April M Bobenchik; Eszter Deak; Janet A Hindler; Carmen L Charlton; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2016-11-23       Impact factor: 5.948

7.  Multicenter Evaluation of a Modified Cefoxitin Disk Diffusion Method and PBP2a Testing To Predict mecA-Mediated Oxacillin Resistance in Atypical Staphylococcus aureus.

Authors:  Shelley A Miller; James Karichu; Peggy Kohner; Nicolynn Cole; Janet A Hindler; Robin Patel; Sandra Richter; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2016-11-30       Impact factor: 5.948

8.  Carbapenem-Resistant Enterobacteriaceae Detection Practices in California: What Are We Missing?

Authors:  Romney M Humphries; Janet A Hindler; Erin Epson; Sam Horwich-Scholefield; Loren G Miller; Job Mendez; Jeremias B Martinez; Jacob Sinkowitz; Darren Sinkowtiz; Christina Hershey; Patricia Marquez; Sandeep Bhaurla; Marcelo Moran; Lindsey Pandes; Dawn Terashita; James A McKinnell
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

9.  Performance of Vitek 2 for antimicrobial susceptibility testing of Enterobacteriaceae with Vitek 2 (2009 FDA) and 2014 CLSI breakpoints.

Authors:  April M Bobenchik; Eszter Deak; Janet A Hindler; Carmen L Charlton; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2014-12-24       Impact factor: 5.948

10.  Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli.

Authors:  Janet A Hindler; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2013-03-13       Impact factor: 5.948
View more
  96 in total

1.  Performance of ceftazidime/avibactam susceptibility testing methods against clinically relevant Gram-negative organisms.

Authors:  E Wenzler; M Lee; T J Wu; K A Meyer; R K Shields; M H Nguyen; C J Clancy; R M Humphries; A T Harrington
Journal:  J Antimicrob Chemother       Date:  2019-03-01       Impact factor: 5.790

2.  Performance of Four Fosfomycin Susceptibility Testing Methods against an International Collection of Clinical Pseudomonas aeruginosa Isolates.

Authors:  Elizabeth C Smith; Hunter V Brigman; Jadyn C Anderson; Christopher L Emery; Tiffany E Bias; Phillip J Bergen; Cornelia B Landersdorfer; Elizabeth B Hirsch
Journal:  J Clin Microbiol       Date:  2020-09-22       Impact factor: 5.948

3.  Azole derivatives with naphthalene showing potent antifungal effects against planktonic and biofilm forms of Candida spp.: an in vitro and in silico study.

Authors:  Suat Sari; Ebru Koçak; Didem Kart; Zeynep Özdemir; M Fahir Acar; Burcu Sayoğlu; Arzu Karakurt; Sevim Dalkara
Journal:  Int Microbiol       Date:  2020-09-05       Impact factor: 2.479

4.  Performance of the BD Phoenix Automated Microbiology System for Trimethoprim-Sulfamethoxazole Susceptibility Testing of Staphylococcus aureus.

Authors:  Ghada N Al-Rawahi; Sam Chorlton; Sukhvinder Dhaliwal; George R Golding; Peter Tilley
Journal:  J Clin Microbiol       Date:  2019-12-23       Impact factor: 5.948

5.  Evaluation of Two Commercial Broth Microdilution Methods Using Different Interpretive Criteria for the Detection of Molecular Mechanisms of Acquired Azole and Echinocandin Resistance in Four Common Candida Species.

Authors:  Ha Jin Lim; Jong Hee Shin; Mi-Na Kim; Dongeun Yong; Seung A Byun; Min Ji Choi; Seung Yeob Lee; Eun Jeong Won; Seung-Jung Kee; Soo Hyun Kim; Myung-Geun Shin
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

6.  Deimmunized Lysostaphin Synergizes with Small-Molecule Chemotherapies and Resensitizes Methicillin-Resistant Staphylococcus aureus to β-Lactam Antibiotics.

Authors:  Yongliang Fang; Jack R Kirsch; Liang Li; Seth A Brooks; Spencer Heim; Cynthia Tan; Susan Eszterhas; Hao D Cheng; Hongliang Zhao; Yan Q Xiong; Karl E Griswold
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

7.  Campylobacter jejuni Antimicrobial Resistance Profiles and Mechanisms Determined Using a Raman Spectroscopy-Based Metabolomic Approach.

Authors:  Luyao Ma; Lei Chen; Keng C Chou; Xiaonan Lu
Journal:  Appl Environ Microbiol       Date:  2021-05-26       Impact factor: 4.792

8.  Comparison of Treatment Outcomes between Analysis Populations in the RESTORE-IMI 1 Phase 3 Trial of Imipenem-Cilastatin-Relebactam versus Colistin plus Imipenem-Cilastatin in Patients with Imipenem-Nonsusceptible Bacterial Infections.

Authors:  Keith S Kaye; Helen W Boucher; Michelle L Brown; Angela Aggrey; Ireen Khan; Hee-Koung Joeng; Robert W Tipping; Jiejun Du; Katherine Young; Joan R Butterton; Amanda Paschke
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

9.  Overcoming Multidrug Resistance and Biofilms of Pseudomonas aeruginosa with a Single Dual-Function Potentiator of β-Lactams.

Authors:  Anh K Lam; Hannah Panlilio; Jennifer Pusavat; Cassandra L Wouters; Erika L Moen; Charles V Rice
Journal:  ACS Infect Dis       Date:  2020-04-06       Impact factor: 5.084

10.  Fungal biofilm architecture produces hypoxic microenvironments that drive antifungal resistance.

Authors:  Caitlin H Kowalski; Kaesi A Morelli; Daniel Schultz; Carey D Nadell; Robert A Cramer
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-26       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.